Precision Biosciences (DTIL) Short term Debt (2021 - 2024)

Precision Biosciences (DTIL) has 3 years of Short term Debt data on file, last reported at $22.5 million in Q2 2024.

• On a quarterly basis, Short term Debt rose 0.79% year-over-year to $22.5 million in Q2 2024; TTM through Jun 2024 was $22.5 million, a 0.79% increase from a year earlier, with the FY2023 full-year figure at $22.4 million, changed N/A from the prior year.
• Short term Debt for Q2 2024 stood at $22.5 million, roughly flat from $22.5 million in the prior quarter.
• Over the last five years, Short term Debt for DTIL reached as high as $22.5 million in Q2 2024 and fell as low as $2.4 million in Q2 2021.
• Historically, Short term Debt has averaged $16.7 million across 3 years, with a median of $22.4 million in 2023.
• On a YoY basis, Short term Debt climbed as much as 0.79% in 2024 and fell as far as 0.79% in 2024.
• Year by year, Short term Debt stood at $2.5 million in 2021, then jumped by 813.28% to $22.4 million in 2023, then grew by 0.37% to $22.5 million in 2024.
• Per Business Quant data, the three most recent Short term Debt figures were $22.5 million in Q2 2024, $22.5 million in Q1 2024, and $22.4 million in Q4 2023.